CD4 lymphocyte dynamics in Tanzanian pulmonary tuberculosis patients with and without hiv co-infection

BMC Infectious Diseases

Volumn 12, Issue , 2012, Pages

  Andersen, Aase B ^a   Range, Nyagosya S ^b   Changalucha, John ^b   PrayGod, George ^b   Kidola, Jeremiah ^b   Faurholt Jepsen, Daniel ^c   Krarup, Henrik ^d   Grewal, Harleen M S ^e   Friis, Henrik ^c  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

^b NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (Tanzania)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

^d AALBORG UNIVERSITY HOSPITAL   (Denmark)

^e HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

CD4 cells; HIV; Pulmonary tuberculosis; TB treatment

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN; TUBERCULOSTATIC AGENT;

ADOLESCENT; ADULT; ARTICLE; CD4+ T LYMPHOCYTE; COHORT ANALYSIS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; ETHNIC GROUP; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LUNG TUBERCULOSIS; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; MIXED INFECTION; PRESCRIPTION; TANZANIAN; TREATMENT DURATION; TREATMENT OUTCOME; TUBERCULOSIS; CASE CONTROL STUDY; CD4 LYMPHOCYTE COUNT; CLINICAL TRIAL; IMMUNOLOGY; MIDDLE AGED; TANZANIA;

ADULT; ANTITUBERCULAR AGENTS; CASE-CONTROL STUDIES; CD4 LYMPHOCYTE COUNT; CD4-POSITIVE T-LYMPHOCYTES; COHORT STUDIES; COINFECTION; FEMALE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; TANZANIA; TUBERCULOSIS, PULMONARY; YOUNG ADULT;

EID: 84858592581     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-12-66     Document Type: Article

References (22)

1. The Antiretroviral Therapy Cohort Collaboration Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies. Lancet 2008, 372:293-299. 3130543, 18657708, The Antiretroviral Therapy Cohort Collaboration.
2. Begtrup K, Melbye M, Biggar RJ, Goedert JJ, Knudsen K, Andersen PK. Progression to acquired immunodeficiency syndrome is influenced by CD4 T-lymphocyte count and time since seroconversion. Am J Epidemiol 1997, 145:629-635.
3. World Health Organization Antiretroviral Therapy for HIV Infection in Adults and Adolescents. 2010 revision. Geneva, World Health Organization.
4. Ellner JJ. Immunoregulation in TB: observations and implications. Clin Transl Sci 2010, 3:23-28. 10.1111/j.1752-8062.2010.00180.x, 20443950.
5. Jones BE, Oo MM, Taikwel EK, Qian D, Kumar A, Maslow ER, et al. CD4 cell counts in human immunodeficiency virus-negative patients with tuberculosis. Clin Infect Dis 1997, 24:988-991. 10.1093/clinids/24.5.988, 9142808.
6. Turett GS, Telzak EE. Normalization of CD4+ T-lymphocyte depletion in patients without HIV infection treated for tuberculosis. Chest 1994, 105:1335-1337. 10.1378/chest.105.5.1335, 7910131.
7. Cingolani A, Cozzi LA, Castagna A, Goletti D, De LA, Scarpellini P, et al. Impaired CD4 T-cell count response to combined antiretroviral therapy in antiretroviral-naive HIV-infected patients presenting with tuberculosis as AIDS-defining condition. Clin Infect Dis 2012, 54:853-861. 10.1093/cid/cir900, 22157323.
8. Praygod G, Range N, Faurholt-Jepsen D, Jeremiah K, Faurholt-Jepsen M, Aabye MG, et al. Daily multi-micronutrient supplementation during tuberculosis treatment increases weight and grip strength among HIV-uninfected but not HIV-infected patients in Mwanza, Tanzania. J Nutr 2011, 144:685-691.
9. Praygod G, Range N, Faurholt-Jepsen D, Jeremiah K, Faurholt-Jepsen M, Aabye MG, et al. Weight, body composition and handgrip strength among pulmonary tuberculosis patients: a matched cross-sectional study in Mwanza, Tanzania. Trans R Soc Trop Med Hyg 2011, 105:140-147. 10.1016/j.trstmh.2010.11.009, 21239027.
10. World Health Organization Treatment of Tuberculosis: Guidelines for National Programmes 2003, World Health Organization publications, Third, WHO/CDS/2003.313, World Health Organization.
11. Ministry of Health and Social Welfare Manual of the National Tuberculosis and Leprosy Programme in Tanzania 2006, Fifth, Ministry of Health and Social Welfare.
12. Ministry of Health, United Republic of Tanzania National Guidelines for the Clinical Management of HIV and AIDS 2005, Second, Ministry of Health, United Republic of Tanzania.
13. Guyot-Revol V, Innes JA, Hackforth S, Hinks T, Lalvani A. Regulatory T cells are expanded in blood and disease sites in patients with tuberculosis. Am J Respir Crit Care Med 2006, 173:803-810. 10.1164/rccm.200508-1294OC, 16339919.
14. Hertoghe T, Wajja A, Ntambi L, Okwera A, Aziz MA, Hirsch C, et al. T cell activation, apoptosis and cytokine dysregulation in the (co)pathogenesis of HIV and pulmonary tuberculosis (TB). Clin Exp Immunol 2000, 122:350-357. 10.1046/j.1365-2249.2000.01385.x, 1905783, 11122240.
15. Hirsch CS, Johnson JL, Okwera A, Kanost RA, Wu M, Peters P, et al. Mechanisms of apoptosis of T-cells in human tuberculosis. J Clin Immunol 2005, 25:353-364. 10.1007/s10875-005-4841-4, 16133992.
16. Blanc FX, Sok T, Laureillard D, Borand L, Rekacewicz C, Nerrienet E, et al. Earlier versus later start of antiretroviral therapy in HIV-infected adults with tuberculosis. N Engl J Med 2011, 365:1471-1481. 10.1056/NEJMoa1013911, 22010913.
17. Havlir DV, Kendall MA, Ive P, Kumwenda J, Swindells S, Qasba SS, et al. Timing of antiretroviral therapy for HIV-1 infection and tuberculosis. N Engl J Med 2011, 365:1482-1491. 10.1056/NEJMoa1013607, 22010914.
18. Jensen L, Jensen AV, Praygod G, Kidola J, Faurholt-Jepsen D, Changalucha J, et al. Infrequent detection of Pneumocystis jirovecii by PCR in oral wash specimens from TB patients with or without HIV and healthy contacts in Tanzania. BMC Infect Dis 2010, 10:140. 10.1186/1471-2334-10-140, 2886059, 20509902.
19. Martin DJ, Sim JG, Sole GJ, Rymer L, Shalekoff S, van Niekerk AB, et al. CD4+ lymphocyte count in African patients co-infected with HIV and tuberculosis. J Acquir Immune Defic Syndr Hum Retrovirol 1995, 8:386-391.
20. Kony SJ, Hane AA, Larouze B, Samb A, Cissoko S, Sow PS, , et al. SIDAK Research Group Tuberculosis-associated severe CD4+ T-lymphocytopenia in HIV-seronegative patients from Dakar. J Infect 2000, 41:167-171. SIDAK Research Group.
21. Morris L, Martin DJ, Bredell H, Nyoka SN, Sacks L, Pendle S, et al. Human immunodeficiency virus-1 RNA levels and CD4 lymphocyte counts, during treatment for active tuberculosis, in South African patients. J Infect Dis 2003, 187:1967-1971. 10.1086/375346, 12792875.
22. Mahan CS, Walusimbi M, Johnson DF, Lancioni C, Charlebois E, Baseke J, et al. Tuberculosis treatment in HIV infected Ugandans with CD4 counts > 350 cells/mm reduces immune activation with no effect on HIV load or CD4 count. PLoS One 2010, 5:e9138. 10.1371/journal.pone.0009138, 2825253, 20179751.